project id: TCGA-PRAD; case submitter id: TCGA-KK-A8I9; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.11; rna integrity number: 8.1; age at index: 61; days to birth: -22295; ethnicity: not reported; gender: male; race: not reported; vital status: Alive; year of birth: 1951; age at diagnosis: 22295; ajcc clinical m: M0; ajcc clinical t: T2b; ajcc pathologic n: N0; ajcc pathologic t: T3a; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 1001.0; icd 10 code: C61; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; primary gleason grade: Pattern 4; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; secondary gleason grade: Pattern 4; site of resection or biopsy: Prostate gland; synchronous malignancy: No; tissue or organ of origin: Prostate gland; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; creation datetime: 1385337600.0; is ffpe: false; portion number: 11; weight: 30.0; composition: Not Reported; days to collection: 528; days to sample procurement: 0; specimen type: Solid Tissue; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0;